Table: Mochida Pharm -Q1 group results

Mochida Pharmaceutical

02/08/2019 06:00

Aug 2 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             26.49               29.80           103.00    
                 (-11.1 pct)         (+2.7 pct)       (-6.1 pct)  
  Operating          4.52                6.17             7.70    
                 (-26.7 pct)         (+3.6 pct)       (-27.3 pct) 
  Recurring          4.67                6.29             8.10    
                 (-25.8 pct)         (+3.1 pct)       (-25.9 pct) 
  Net                3.31                5.84             5.80    
                 (-43.4 pct)         (+35.3 pct)      (-31.2 pct) 
  EPS             84.25 yen          147.19 yen       147.85 yen  
  Ann Div                            170.00 yen        80.00 yen  
  -Q2 div                             80.00 yen        40.00 yen  
  -Q4 div                             90.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T